Suppressive effects of monocytic cells and transforming growth factor-beta on natural killer cell differentiation in

G C Koo1, C L Manyak, J Dasch

  • 1Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065.

Insights

Motheaten (mev) mice have defective Natural Killer (NK) cell activity due to suppressive adherent cells. Transforming growth factor-beta (TGF-β) from these cells impairs NK cell differentiation, offering a target for therapeutic intervention.

Area of Science:

  • Immunology
  • Genetics

Background:

  • Motheaten (mev) mice exhibit inflammatory and arthritic conditions with impaired immune cell function.
  • Reduced Natural Killer (NK) cell activity is a noted characteristic of mev mice.

Purpose of the Study:

  • To investigate the basis of decreased NK cell activity in mev mice.
  • To identify the cellular and molecular mechanisms underlying defective NK cell differentiation.

Main Methods:

  • Analysis of NK cell differentiation in spleen and bone marrow cells from mev mice.
  • Enrichment of spleen cells using nylon wool passage to assess NK cell precursors.
  • Co-culture experiments with adherent cells from mev mice and normal splenic populations.
  • Characterization of suppressive adherent cells using surface markers (F4/80, AsGm-1, Qa-5, NK-1.1).
  • Testing the effect of cytokine-neutralizing antibodies, including anti-TGF-beta antibody.

Main Results:

  • NK cell precursors were present in mev mice but required enrichment for functional assessment.
  • Adherent cells from mev mice suppressed NK cell differentiation from normal spleen cells.
  • These suppressive cells expressed specific surface markers and were not cytolytic.
  • The suppressive effect was partially reversed by anti-TGF-beta antibody, but not by antibodies against IFN or TNF-alpha.

Conclusions:

  • Defective NK cell differentiation in mev mice is mediated by suppressive adherent cells.
  • Transforming growth factor-beta (TGF-β) plays a significant role in this suppression.
  • Targeting TGF-β may offer a therapeutic strategy for immune dysfunction in mev mice.

Related Concept Videos